Anti-Malaria HRP II Monoclonal Antibody (IgG1) is a highly specific and sensitive antibody designed to detect histidine-rich protein II (HRP II), a biomarker for Plasmodium falciparum, the parasite responsible for severe malaria infections. This monoclonal antibody plays a critical role in diagnostic, research, and IVD manufacturing applications. Its precision and reliability make it an essential tool for rapid diagnostic tests and immunological studies related to malaria.

Diagnostic Testing:
Used in ELISA, immunoassays, and rapid diagnostic tests to detect HRP II antigens in clinical samples. Enables accurate identification of Plasmodium falciparum infections, aiding in the timely diagnosis and treatment of malaria.

Research & Development:
Supports research into malaria pathogenesis and immune response mechanisms. Facilitates the development of novel diagnostic tools and therapeutic strategies targeting malaria biomarkers.

IVD Manufacturing:
Integral in the production of malaria diagnostic kits, ensuring high sensitivity and specificity in detecting HRP II antigens. Provides consistent and reproducible results across various assay platforms used in clinical and laboratory settings.